Quick Summary
Myciclib 75mg Capsule
Last updated on 13 Jul 2026 | 07:11 AM (IST)
₹2929
MRP: ₹6176
(You Save ₹3247)
21 CAPSULE(s) IN A BOTTLE
53% OFF
₹2929
MRP: ₹6,176.00
Inclusive of all taxes
53% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Palbokaas 75mg Capsule
ANAKAAS LIFE BI...
₹ 85.71/capsule
38% cheaper
Ciclib 75mg Capsule
SHILPA MEDICARE...
₹ 110.52/capsule
20% cheaper
Piclib 75mg Capsule
HETERO HEALTHCA...
₹ 115.43/capsule
17% cheaper
Palnat 75mg Capsule
NATCO PHARMA LT...
₹ 125.00/capsule
10% cheaper
Introduction to Myciclib 75mg Capsule
Myciclib 75mg capsule is a targeted therapy containing the active constituent palbociclib. It belongs to the group of anticancer medications known as a cyclin-dependent kinase inhibitors. It is used in treating hormone receptor-positive, human epidermal growth factor 2 negative advanced or metastatic (has spread to other parts of the body) breast cancer. Cancer is a condition in which cells multiply in an uncontrolled and abnormal manner. It is given in combination with certain other anticancer medications.
The common side effects that are likely to associate with Myciclib 75mg capsule are nausea, vomiting, diarrhea, tiredness, hair loss, dry skin, rash, infections, nose bleed, decreased appetite, low blood cell counts, swelling of lips and mouth, changes in taste, dry eye, blurred vision, and increased tearing. Inform your doctor if any of these side effects disturb or persists in you.
Inform your healthcare provider if you are allergic to Myciclib 75mg capsule and its ingredients. Before taking this medicine, it is vital to inform your doctor if you have any signs of infections (fever, chills, or sore throat), liver disorders, kidney disorders, or intolerance to some sugars. Consult your physician immediately if you experience symptoms such as dry cough, chest pain, difficulty breathing, as it could indicate lung inflammation. Make sure you inform your physician of all the medicines, including supplements and herbal medicines, you are taking before you start treatment with this medication. Use effective birth control during the treatment and at least three weeks after the last dose. It is not recommended for adolescents and children under 18 years of age.
Uses of Myciclib 75mg Capsule
- Treatment of hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative advanced or metastatic breast cancer.
Therapeutic Effects of Myciclib 75mg Capsule
Myciclib 75mg capsule works by blocking the protein called cyclin-dependent kinases 4 and 6, which are vital for the division and growth of cells. By blocking these proteins, this medication slows the growth and prevents the cancer cells from spreading.
Interaction of Myciclib 75mg Capsule with other drugs
Inform your doctor about any medications you are taking or have taken before the treatment. Concurrent use of Myciclib 75mg capsule with CYP3A4 inhibitors such as fentanyl has reported in increased fentanyl toxicity.
More Information about Myciclib 75mg Capsule
- Keep Myciclib 75mg capsule out of sight and reach of children.
Store at 20°C to 25°C.
How to consume Myciclib 75mg Capsule
Take Myciclib 75mg capsule exactly as prescribed by your doctor. Take this medication once a day at the same time with food. Swallow this capsule as a whole with a glass of water. Avoid crushing, breaking, or chewing the capsule.
Safety Advice for Myciclib 75mg Capsule
Breast Feeding
It is not recommended to take Myciclib 75mg capsule while breastfeeding as it is not known whether it passes into the breast milk.
Alcohol
It is unknown whether it is safe to drink alcohol while taking Myciclib 75mg capsule. Check with your doctor for advice.
Liver
Inform your physician if you have any liver disorders before taking Myciclib 75mg capsule, as it should be used with caution in liver disorder patients.
Lungs
Inform your physician if you have any lung disorders before taking Myciclib 75mg capsule, as it should be used with caution in lung disorder patients.
Driving
Myciclib 75mg capsule can cause tiredness. Avoid driving if you are unwell.
Pregnancy
It is not recommended to take Myciclib 75mg capsule during pregnancy as it can harm the unborn baby. Women with childbearing potential should use effective contraceptives during treatment and for at least three weeks after treatment.
Side Effects of Myciclib 75mg Capsule
Side effects are unwanted symptoms caused by medicines. Although all drugs cause side effects, not everyone experiences them.
Common
- Bleeding at the injection site
- Pain in chest
- Recurrent ischaemia (reduction in the blood supply)
- Heart failure
- Pulmonary oedema
- Low blood pressure
- Shortness of breath
- Burning sensation
- Bleeding in the digestive tract (blood vomiting), urinary tract, gums
- Abnormal heart function (arrhythmias)
Word of Advice
Before taking the medication, it's essential to discuss your medical history if you have a bleeding disorder, stomach or small intestine ulcers, enlarged blood vessels in the food pipes, or high blood pressure. The blood pressure of the patient should be monitored before administering the medicine to avoid complications caused by the drug. You can apply gentle pressure to avoid bleeding at the injection site.
FAQs about Myciclib 75mg Capsule
Q1.
Is Myciclib 75mg capsule targeted therapy?
Yes, Myciclib 75mg capsule is a targeted therapy. This medication belongs to the class of cyclin-dependent kinase inhibitors.
Q2.
Do you lose hair on Myciclib 75mg capsule?
Yes, Taking Myciclib 75mg capsule can cause hair loss or hair thinning. It is one of the side effects of this medication. Consult your doctor if any side effects disturb you.
Q3.
Can children use Myciclib 75mg capsule?
No, Myciclib 75mg capsule is not recommended for adolescents and children under 18.
Q4.
Does Myciclib 75mg capsule affect fertility?
Yes, Myciclib 75mg capsule may reduce fertility in men. It may affect your ability to become a father and a child. Hence, men should consider sperm preservation before taking this medication.
Q5.
Does Myciclib 75mg capsule affect blood cell count?
Myciclib 75mg capsule might reduce the number of white blood cells and weaken the immune system. It could lead to an increase in the risk of infections. Regular blood tests while taking Myciclib 75mg tablet are advised.
Fact Box of Myciclib 75mg Capsule
| Molecule Name: Palbociclib | Therapeutic class: Cyclin-dependent kinase inhibitor |
Pharmacological class: Anticancer agents | Indication: 1. HR-positive 2. HER2-negative advanced or metastatic breast cancer |
| Dosage form: Capsule | Habit forming: No |
References
- Pfizer Limited, Electronic medicines compendium (emc), [Revised on June 2021] [ Accessed on 26 Nov 2022], https://www.medicines.org.uk/emc/files/pil.4449.pdf
- Pfizer Labs, US Food and Drug Administration, [Revised on March 2017] [ Accessed on 26 Nov 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207103s004lbl.pdf
- Neha S Mangini et al; Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer; The Annals of Pharmacotherapy; Published on Nov 2015; Accessed on 26/11/2022; https://pubmed.ncbi.nlm.nih.gov/26324355/
- Palbace; Pfizer; Revised on Oct 2021; Accessed on 26/11/2022; https://labeling.pfizer.com/ShowLabeling.aspx?id=14029
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Guruvigneshwari M.
M. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 13 Jul 2026 | 07:11 AM (IST)
Want to know more?
Read Our Editorial Policy
